Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
48 report e oltre
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Plato Raises $16M Series A for AI Training Simulations
Plato raised a $16 million Series A led by Nava Ventures to expand its library of real-world work experience for simulated AI training environments.
Microbiotica Raises £36M Series C for Oral Microbiome Medicines
Microbiotica announced the first close of a £36 million ($48 million) Series C led by British Business Bank to advance MB310 into Phase 2 clinical development in ulcerative colitis.
Mogul Raises $15.5M Series A for AI Real Estate Investing
Mogul raised a $15.5 million Series A led by Draper Associates to scale its AI infrastructure, expand its property portfolio, and create new revenue streams.
IPID Raises $16M Series A for Payment Intelligence and Payee Verification
IPID raised a $16 million Series A led by Foundation Capital, with Citi and HSBC participating, to deepen its payment intelligence network and grow in the United States and Europe.
Chamelio Raises $26M Series A for AI-Native Legal Operations
Chamelio raised a $26 million Series A led by Entrée Capital to replace legacy contract-management systems with agentic legal operations.
Xapien Raises $56M Growth Investment for AI Due Diligence
Xapien raised a $56 million growth investment round led by Spectrum Equity to build out its U.S. presence for its AI-native due diligence platform.
Wint Raises $36M Series D for AI-Powered Water Management
Wint raised a $36 million Series D co-led by LIP Ventures and Inven Capital to accelerate product development and deepen its market reach in AI-powered water management.
Typewriter Therapeutics Raises $56M Series A for In Vivo CAR T Medicines
Typewriter Therapeutics emerged from stealth with a $56 million Series A led by AN Venture Partners and RA Capital Management to develop in vivo CAR T medicines.
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.